Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Avanceret styring af overfladebehandlingsprocesser | 2016 - 2017 | Innobooster
|
|
|
Avanceret styring af overfladebehandlingsprocesser
Period
2016 - 2017
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
29.53 Invested
490.130 Budget
1.7 mill. Partners
Airtech A/S People
AIRTECH A/S
Read more about the project
| |||
| AVENGERS - Arterio-VENous Graft for Early vasculaR access and prevention of Stenosis for dialysis patients | 2021 - 2022 | Innobooster
|
|
|
AVENGERS - Arterio-VENous Graft for Early vasculaR access and prevention of Stenosis for dialysis patients
Period
2021 - 2022
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
499.950 Budget
1.5 mill. Partners
Biomodics Aps People
Biomodics ApS
Read more about the project
| |||
| Avidity and multivalent target engagement in antibodies | 2020 - 2023 | Industrial Researcher
|
|
|
Avidity and multivalent target engagement in antibodies
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
51.17 Invested
1.1 mill. Budget
2.1 mill. Partners
Aarhus University, Novo Nordisk A/S - G8, x9 m.fl. People
Novo Nordisk A/S - G8, x9 m.fl.
Read more about the project
| |||
| AVLX-144 as a novel treatment for ischemic stroke 144STROKE | 2019 - 2021 | Grand Solutions
|
|
|
AVLX-144 as a novel treatment for ischemic stroke 144STROKE
Period
2019 - 2021
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
75.07 Invested
19.9 mill. Budget
26.5 mill. Partners
University of Copenhagen, Avilex Pharma, Copenhagen University Hospital (Rigshospitalet), University of Southern Denmark, Clinical Research Services Turku, Turku PET Center People
AVILEX PHARMA ApS
Read more about the project
| |||
| AVS Agric | 2018 - 2020 | Innobooster
|
|
|
AVS Agric
Period
2018 - 2020
Region
Region Syddanmark Program
Innobooster Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
31.8 Invested
345.000 Budget
1.1 mill. Partners
AVS Agric People
AVS Agric Aps
Read more about the project
| |||
| AW Technologies: Clinical study with TrachFlush | 2022 - 2023 | Innobooster
|
|
|
AW Technologies: Clinical study with TrachFlush
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
231.000 Budget
660.000 Partners
AW Technologies ApS People
Read more about the project
| |||
| AW Technologies: First clinical study with TrachSpeak | 2021 - 2022 | Innobooster
|
|
|
AW Technologies: First clinical study with TrachSpeak
Period
2021 - 2022
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
424.463 Budget
1.3 mill. Partners
AW Technologies People
AW Technologies ApS
Read more about the project
| |||
| AW Technologies: First in-human study with TrachFlush | 2021 - 2021 | Innobooster
|
|
|
AW Technologies: First in-human study with TrachFlush
Period
2021 - 2021
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
29.83 Invested
388.575 Budget
1.3 mill. Partners
AW Technologies People
AW Technologies ApS
Read more about the project
| |||
| AW Technologies: Pre-clinical safety trial for TrachFlush | 2020 - 2020 | Innobooster
|
|
|
AW Technologies: Pre-clinical safety trial for TrachFlush
Period
2020 - 2020
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
22.63 Invested
349.530 Budget
1.5 mill. Partners
AW Technologies People
AW Technologies ApS
Read more about the project
| |||
| AWAPAVE Avancerede og let-tilgængelige tilstands-måleværktøjer til infrastruktur evaluering | 2016 - 2018 | Grand Solutions
|
|
|
AWAPAVE Avancerede og let-tilgængelige tilstands-måleværktøjer til infrastruktur evaluering
Period
2016 - 2018
Region
Region Hovedstaden Program
Grand Solutions Area
Ikke defineret Investment
Percentage
61.25 Invested
12.0 mill. Budget
19.5 mill. Partners
Dynatest International A/S, Technical University of Denmark, Technical University of Denmark People
Datoselskabet af 6. marts 1981 A/S
Read more about the project
| |||
| AWARE-AI | 2024 - 2025 | Innoexplorer
|
|
|
AWARE-AI
Period
2024 - 2025
Region
Program
Innoexplorer Area
Ikke defineret Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
KU - SUND - PANUM KBH N People
Read more about the project
| |||
| Awareness VR - Markedsklar real-world VR-træningssoftware til fremtidens sikkerhedsvagter | 2022 - 2023 | Innobooster
|
|
|
Awareness VR - Markedsklar real-world VR-træningssoftware til fremtidens sikkerhedsvagter
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
34.92 Invested
398.999 Budget
1.1 mill. Partners
Awareness VR ApS People
Read more about the project
| |||
| Awayste - Innobooster | 2021 - 2021 | Innobooster
|
|
|
Awayste - Innobooster
Period
2021 - 2021
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
487.542 Budget
1.5 mill. Partners
Lyngsøe A/S People
LYNGSØE A/S
Read more about the project
| |||
| Axion - Attention Manager for Compulsive Digital Habits | 2026 - 2027 | Innofounder
|
|
|
Axion - Attention Manager for Compulsive Digital Habits
Period
2026 - 2027
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
430.000 Budget
430.000 Axion er en applikation der skal hjælpe brugerene med at undgå compulsiv digital adfærd, spildtid og for høj skærmtid på mobil og computer. Axion giver et overblik over brugerens digitale vaner, og giver mulighed for at tage handlinger for at begrænse uønsket brug af digitale apps og websites. Axion er innovativ med hensyn til hvordan analyse og kompliceret adfærdsændrende teknologi kombineres i en applikation. Da skærmtid er et alvorligt og voksende sundhedsproblem i danmarks befolkning, kan Axion hjælpe mennesker der er klar over deres negative skærmadfærd med at gøre noget ved det.
Innovationsfondens investering vil hjælpe os med at videreudvikle og senere finpudse vores eksisterende app til Android. Vi kommer også til at udvide til iOS og Windows, samt udvide kapacitererne og generelt designe en bedre brugeroplevelse. Uden investeringen ville det have været vanskeligt at arbejde nok på applikationen til at den kunne blive kommercielt fornuftig og opnå et kvalitetsniveau der ville være højt nok til at tiltrække mange brugere.
På længere sigt vil vi gå efter at blive en tvær-kompatibel skærmtids analyse- og reduktionsapp, der leverer en brugervenlig, bevidst, og komplet løsning for vores brugere der ønsker at få kontrol over deres digitale vaner. Vi ønsker at være den dominerende applikation på markedet, og gøre det nemt at få fuld kontrol over sine skærmvaner.
Partners
AxionHQ ApS People
AxionHQ ApS
Read more about the project
| |||
| B celler og antistoffer i antitumor immunitet i colorectal cancer | 2021 - 2024 | Industrial Researcher
|
|
|
B celler og antistoffer i antitumor immunitet i colorectal cancer
Period
2021 - 2024
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
47.68 Invested
1.1 mill. Budget
2.2 mill. Partners
Technical University of Denmark, Symphogen A/S People
Symphogen A/S
Read more about the project
| |||